Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases

Yingqing Chen,Minli Tang,Shuo Yuan,Shuang Fu,Yifei Li,You Li,Qi Wang,Yuying Cao,Liping Liu,Qinggao Zhang
DOI: https://doi.org/10.1155/2022/1348795
2022-02-27
Oxidative Medicine and Cellular Longevity
Abstract:Cardiovascular diseases, also known as circulatory diseases, are diseases of the heart and blood vessels, and its etiology is hyperlipidemia, thick blood, atherosclerosis, and hypertension. Due to its high prevalence, disability, and mortality, it seriously threatens human health. According to reports, the incidence of cardiovascular disease is still on the rise. Rhodiola rosea is a kind of traditional Chinese medicine, which has the effects of antimyocardial ischemia-reperfusion injury, lowering blood fat, antithrombosis, and antiarrhythmia. Rhodiola rosea has various chemical components, and different chemical elements have the same pharmacological effects and medicinal values for various cardiovascular diseases. This article reviews the research on the pharmacological effects of Rhodiola rosea on cardiovascular diseases and provides references for the clinical treatment of cardiovascular diseases.
cell biology
What problem does this paper attempt to address?